Or Eisenberg Insider Profile
4 Followers
Or Eisenberg, CFO at Neurosense Therapeutics Ltd., holds 1.50M shares in Neurosense Therapeutics Ltd. (Ticker: NRSN), holds 1.01M shares in Big Digital Energy (Ticker: BGDE). Most recently, Or Eisenberg Bought ― shares of Neurosense Therapeutics Ltd. on Jun 17, 2026 for an estimated value of $200.00K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-56.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Or Eisenberg holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 17, 2026 - Today
Return:-50.70%
The most profitable trade made by Or Eisenberg
Or Eisenberg's Trading History
Neurosense Therapeutics Ltd.
Jun 17, 2026
CFO
Informative Buy
200.00K
$521.91K
Big Digital Energy
Mar 11, 2021
CFO & Sec
Informative Buy
100.00K
$6.88M
List of latest transactions for each holding click on a transaction to see Or Eisenberg's performance on stock
You May Also Like
Or Eisenberg insider profile FAQ
What is the percentage of profitable transactions made by Or Eisenberg?
The percentage of profitable transactions made by Or Eisenberg is 0%.
What is the average return per transaction made by Or Eisenberg?
The average return per transaction made by Or Eisenberg is -56.20%.
What stocks does Or Eisenberg hold?
Or Eisenberg holds: NRSN, BGDE stocks.
What was Or Eisenberg’s latest transaction?
Or Eisenberg latest transaction was an Informative Buy of $200.00K.
What was Or Eisenberg's most profitable transaction?
Or Eisenberg’s most profitable transaction was an Informative Buy of NRSN stock on June 17, 2026. The return on the trade was -50.70%.
What is Or Eisenberg's role in Neurosense Therapeutics Ltd.?
Or Eisenberg's role in Neurosense Therapeutics Ltd. is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.